- Report
- July 2025
- 52 Pages
Global
From €6661EUR$7,500USD£5,819GBP
- Report
- June 2025
Global
From €6661EUR$7,500USD£5,819GBP
- Report
- April 2025
- 52 Pages
Global
From €6661EUR$7,500USD£5,819GBP
- Report
- April 2025
- 15 Pages
Global
From €8876EUR$9,995USD£7,754GBP
- Clinical Trials
- March 2025
- 490 Pages
Global
From €3064EUR$3,450USD£2,677GBP
- Newsletter
- December 2025
- 88 Pages
Global
€1171EUR$1,318USD£1,023GBP
- Report
- October 2025
- 140 Pages
Global
From €3661EUR$4,123USD£3,198GBP
€4307EUR$4,850USD£3,763GBP
- Report
- October 2025
- 96 Pages
Global
From €4307EUR$4,850USD£3,763GBP
- Report
- September 2025
- 137 Pages
Global
From €3661EUR$4,123USD£3,198GBP
€4307EUR$4,850USD£3,763GBP
- Report
- February 2025
- 135 Pages
Global
From €3661EUR$4,123USD£3,198GBP
€4307EUR$4,850USD£3,763GBP
- Report
- August 2025
- 100 Pages
Middle East
From €4396EUR$4,950USD£3,840GBP
- Report
- April 2025
- 125 Pages
United States
From €2886EUR$3,250USD£2,521GBP
- Report
- October 2025
- 87 Pages
Middle East
From €4307EUR$4,850USD£3,763GBP
- Report
- June 2023
- 289 Pages
Global
From €4680EUR$5,454USD£3,950GBP
- Report
- April 2018
- 97 Pages
Global
From €14209EUR$16,000USD£12,413GBP
- Report
- June 2023
- 186 Pages
Global
From €4130EUR$4,650USD£3,608GBP
- Report
- June 2022
- 124 Pages
Global
From €4885EUR$5,500USD£4,267GBP
- Report
- September 2023
- 168 Pages
Global
From €5284EUR$5,950USD£4,616GBP
- Report
- March 2023
- 150 Pages
Global
From €5284EUR$5,950USD£4,616GBP
- Report
- December 2022
- 153 Pages
Global
From €2331EUR$2,625USD£2,037GBP
€4662EUR$5,250USD£4,073GBP

Lung cancer is a type of cancer that originates in the lungs. It is the leading cause of cancer-related death worldwide. Oncology is the branch of medicine that deals with the diagnosis, treatment, and prevention of cancer. Lung cancer is one of the most common types of cancer treated by oncologists. Treatment options for lung cancer include surgery, chemotherapy, radiation therapy, and targeted therapy.
The lung cancer market is a rapidly growing segment of the oncology market. It is driven by the increasing prevalence of lung cancer, advances in treatment options, and the increasing availability of targeted therapies. The market is expected to continue to grow in the coming years due to the increasing demand for better treatments and the development of new therapies.
Some companies in the lung cancer market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more